Hathal Haddad, Head of Interventional Radiotherapy Unit at the Department of Radiation Oncology at University Hospital Tübingen, shared post on X:
“Thank you, Peter Orio, for your excellent talk on LDR Brachytherapy with Palladium-103 and its important role in focal therapy for prostate cancer.
It was a pleasure meeting you again after ESTRO2024 in Glasgow and discussing the future of prostate brachytherapy.
Inspiring science, innovation, and patient-centered care.”
Other articles about Prostate Cancer on OncoDaily.